Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terfenadine in Relapsing-Remitting Multiple Sclerosis
NCT07827716Phase 2Recruiting
- Sponsor
- Chuan Qin
- Start
- Aug 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of terfenadine in relapsing-remitting multiple sclerosis (RRMS), sponsored by Chuan Qin. Started Aug 2026; status: recruiting.
02
Drugs
terfenadine
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT07827716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07827716.